These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26298057)

  • 1. Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.
    Hurley MN; ; Prayle AP; Flume P
    Paediatr Respir Rev; 2015 Sep; 16(4):246-8. PubMed ID: 26298057
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystic Fibrosis Frequently Asked Questions: Question 4: What is the appropriate duration of therapy for respiratory exacerbations in Cystic Fibrosis patients infected with Pseudomonas aeruginosa?
    Sutton KM; Fitzgerald DA
    Paediatr Respir Rev; 2016 Jan; 17():60-2. PubMed ID: 25982382
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucocorticoids as an adjuvant treatment to intravenous antibiotics for cystic fibrosis pulmonary exacerbations: a UK Survey.
    Hester KL; Powell T; Downey DG; Elborn JS; Jarad NA
    J Cyst Fibros; 2007 Jul; 6(4):311-3. PubMed ID: 17291836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic treatment strategies in cystic fibrosis].
    Smaczny C
    Pneumologie; 1996 Dec; 50 Suppl 3():831-3. PubMed ID: 9157437
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Ryan G; Jahnke N; Remmington T; Smyth A
    Paediatr Respir Rev; 2013 Mar; 14(1):27-8. PubMed ID: 23228327
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of β-lactams as single agents for treating severe pulmonary exacerbations during pregnancy in cystic fibrosis.
    Prickett M; Jain M
    Am J Respir Crit Care Med; 2012 Dec; 186(12):1310-1. PubMed ID: 23250504
    [No Abstract]   [Full Text] [Related]  

  • 7. Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis.
    Bosso JA; Black PG; Matsen JM
    Am J Med; 1987 Apr; 82(4A):180-4. PubMed ID: 3555033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cystic fibrosis: current therapy. Inhalation antibiotics].
    Mordasini C
    Schweiz Med Wochenschr Suppl; 2000; 122():43S-44S. PubMed ID: 12536472
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current treatment of cystic fibrosis].
    Escobar Castro H; Máiz Carro L
    Rev Clin Esp; 1999 Aug; 199(8):541-5. PubMed ID: 10522440
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cystic fibrosis: current therapy. Antibiotics].
    Tamm M; Héritier F; Rappaz I; Schaad UB
    Schweiz Med Wochenschr Suppl; 2000; 122():33S-37S. PubMed ID: 12536469
    [No Abstract]   [Full Text] [Related]  

  • 11. Restoring airway surface liquid in cystic fibrosis.
    Ratjen F
    N Engl J Med; 2006 Jan; 354(3):291-3. PubMed ID: 16421371
    [No Abstract]   [Full Text] [Related]  

  • 12. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.
    Westerman EM; Heijerman HG; Frijlink HW
    Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic use in cystic fibrosis.
    Eisenberg JD
    Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of nebuliser therapy in cystic fibrosis.
    Geddes D
    Prof Care Mother Child; 1995; 5(6):147, 149. PubMed ID: 8680235
    [No Abstract]   [Full Text] [Related]  

  • 15. Value of inhaled antibiotics in cystic fibrosis patients.
    Wunderlich P; Paul KD; Wehner J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):34-6. PubMed ID: 2130713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Exacerbations in Children with Cystic Fibrosis.
    Waters V; Ratjen F
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S200-6. PubMed ID: 26595740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of cystic fibrosis. Observations on gentamycin when used with other antibiotics in pulmonary infections associated with cystic fibrosis.
    Shwachman H; Khaw KT; Kowalski SM
    Clin Pediatr (Phila); 1975 Dec; 14(12):1115-8. PubMed ID: 1192683
    [No Abstract]   [Full Text] [Related]  

  • 18. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
    Hubert D; Desmazes-Dufeu N; Dusser D
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of inhaled tobramycin in patients with cystic fibrosis].
    Chermenskiĭ AG; Gembitskaia TE
    Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.
    Flume PA; Mogayzel PJ; Robinson KA; Goss CH; Rosenblatt RL; Kuhn RJ; Marshall BC;
    Am J Respir Crit Care Med; 2009 Nov; 180(9):802-8. PubMed ID: 19729669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.